A group of mothers in Victoria say they've experienced trouble accessing the jab for a highly infectious illness that infects ...

Canada hosted ITF Masters events in Mont-Tremblant and Ottawa over the past month, with the hosts dominating the latter.

The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...

Medical staff in Western Australia have been warned after reports of the wrong immunisations being given to patients. The ...

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...

Gilead Sciences has blamed the low rate of respiratory syncytial virus (RSV) infections last season for ending two midstage ...

Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...

Pfizer is also running a phase 3 trial of Abrysvo in adults aged 18 to 59 at elevated risk of RSV disease due to chronic medical conditions, but data from that isn't due until later this year.

At the moment, Pfizer's Abrysvo and Moderna's mResvia – currently the only other approved RSV vaccines in the EU for older adults – are only approved for the over-60 age bracket, so Arexvy has ...

Reuters.com is your online source for the latest Middle-East news stories and current events, ensuring our readers up to date with any breaking news developments ...